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Background/Objectives: Coffee is the most widely consumed beverage in the world, but its effect on the cardiovascular system
has not been fully understood. Coffee contains caffeine and antioxidants, which may influence endothelial function, both of
which have not yet been investigated. The objective of this study was to investigate the acute effects of coffee on endothelial
function measured by brachial artery flow-mediated dilation (FMD).
Subjects/Methods: A total of 20 (10 males and 10 females) healthy non-obese subjects underwent a double-blind, crossover
study. Subjects ingested one cup of caffeinated (CC) and one cup of decaffeinated (DC) Italian espresso coffee in random order
at 5- to 7-day intervals.
Results: Following CC ingestion, FMD decreased progressively and significantly (mean±s.e.m.: 0min, 7.7±0.6; 30min,
6.3±0.7; 60min, 6.0±0.8%; ANOVA (analysis of variance), Po0.05), but it did not significantly increase after DC ingestion
(0min, 6.9±0.6; 30min, 8.1±0.9; 60min, 8.5±0.9%; P¼ 0.115). Similarly, CC significantly increased both systolic and
diastolic blood pressure; this effect was not observed after DC ingestion. Blood glucose concentrations remained unchanged
after ingestion of both CC and DC, but insulin (0min, 15.8±0.9; 60min, 15.0±0.8mU/ml; Po0.05) and C-peptide (0min,
1.25±0.09; 60min, 1.18±0.09 ng/ml; Po0.01) blood concentrations decreased significantly only after CC ingestion.
Conclusions: CC acutely induced unfavorable cardiovascular effects, especially on endothelial function. In the fasting state,
insulin secretion is also likely reduced after CC ingestion. Future studies will determine whether CC has detrimental clinically
relevant effects, especially in unhealthy subjects.
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Introduction
Coffee, a major source of caffeine (Frary et al., 2005), is the
most widely consumed beverage in the world. It is manu-
factured under various formulations and preparations.
Although not all components of coffee have been fully
identified, some phenolic components, such as those of the
family of chlorogenic acids, are well known to be abundant
in coffee and possess high antioxidant capacity (Fujioka and
Shibamoto, 2008). Information with regard to the metabolic
and cardiovascular effects of coffee has been conflicting
(Greenberg et al., 2006; Bonita et al., 2007; Klatsky et al.,
2008). Short-term studies on the acute effects of coffee
intake have generally reported detrimental cardiovascular
and metabolic influences (Mahmud and Feely, 2001; Moisey
et al., 2008; Riksen et al., 2009). In some instances,
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epidemiological studies have indicated that regular con-
sumption of coffee is associated with lower risk of cardio-
vascular disease and type 2 diabetes (Silletta et al., 2007;
Larsson et al., 2008; Odegaard et al., 2008; van Wounden-
bergh et al., 2008; Van Dam and Hu, 2008). A possible
explanation for this ‘coffee paradox’ is related to both the
caffeine and the antioxidant content in coffee, as the latter
may be efficacious in the long term, whereas the former may
have more immediate effects. Therefore, understanding the
potential biological effects of coffee may have important
public health implications.
Impaired endothelial function is involved in the patho-
genesis of atherosclerosis and cardiovascular diseases, and is
characterized by a reduction in the bioavailability of nitric
oxide, a potent vasodilator and inhibitor of platelet adhesion
and aggregation with antiinflammatory and antiproliferative
properties (Fuchgott and Zawadzki, 1980; Deanfield et al.,
2007). Endothelial function is measured in vivo by flow-
mediated dilation (FMD) in the brachial artery, and has
proven to be a strong predictor of cardiovascular events
(Gokce et al., 2002; Widlansky et al., 2003; Yeboah et al.,
2007; Rossi et al., 2008). FMD is influenced by many factors,
including insulin resistance, diabetes, drugs and diet (Vogel
et al., 2000; Wu and Meininger, 2002; Hamdy et al., 2003;
Keogh et al., 2005; Shimabukuro et al., 2007). Inflammation
and oxidative stress influence endothelial function and have
a crucial role in atherogenesis (Libby et al., 2002). However,
the data have been conflicting, showing that coffee con-
sumption is either inversely (Lopez-Garcia et al., 2006) or
positively (Zampelas et al., 2004) associated with C-reactive
protein, interleukin-6 and tumor-necrosis factor-a.
Owing to the limited data on the effect of coffee on
endothelial function, the aim of this study was to investigate
the acute effects of caffeinated coffee (CC) vs decaffeinated
coffee (DC), prepared as Italian espresso coffee, on FMD and
some post-absorptive fasting measures of glucose metabo-
lism in healthy subjects.
Subjects and methods
Subjects
A total of 20 non-obese healthy hospital employees volunta-
rily participated in the study after responding to an
announcement in the medical center. There was no
incentive provided to the participants. The study period
was from November 2007 to February 2008. Inclusion
criteria included ages 25–50 years and body mass index
(body weight (kg)/height (m)2) of 20–28 kg/m2. Exclusion
criteria included patients with any dyslipidemia, hyper-
tension, diabetes, cardiovascular or systemic disease, any
medication treatment, smoking of any tobacco products,
pregnancy or lactation in the past 6 months, habitual daily
consumption of greater than two cups of coffee or weekly
ingestion of more than one commercial caffeinated beverage
and abstaining from chocolate or other flavonoid-containing
beverages up to the preceding day. The study protocol was
approved by the ethics committee of the University Hospital
Policlinico P. Giaccone of Palermo, Italy, and an approved
informed consent form was signed by each subject. This
study is registered as an International Standardized Rando-
mized Controlled Trial (ISRCTN85096812).
Study design
The study followed a randomized, crossover, double-blind
design with each subject receiving two different study
treatments, in random order, and repeated on separate days
at 5- to 7-day intervals. Anthropometric measurements,
routine blood tests and an oral glucose (75 g) tolerance test
were obtained in all subjects before participating in the
study by MRT, SB, AM, AR and GP, who were blinded to
study participant randomization. Subjects were tested in
the morning after an overnight fast; women underwent
measurements between the 7th and the 21st day from their
menstrual cycle. FMD of the brachial artery was performed
by the same operator (SB) who was blinded to the
participant’s mixture of coffee tested before, 30min and
60min after drinking a cup of Italian espresso CC or DC;
ultrasound images were video recorded and analyzed by a
trained reader who was blinded to the participant’s mixture
of coffee tested (SV). A venous blood sample was taken before
and 60min after coffee ingestion. Subjects had continuous
electrocardiogram and blood pressure (10min intervals)
recorded for the duration of each test. Serum samples
obtained at each time point of the study were frozen at
80 1C for subsequent analysis.
Coffee testing
Fresh CC or DC was prepared using a commercial automatic
machine (easy serving espresso; Italy) by a blinded study
nurse. The blinding process involved a coffee envelope that
was coded anonymously by the Morettino farm, only to be
decoded by means of a code at the conclusion of the study.
One cup of coffee consisted of 25ml of espresso obtained
with an average extraction time of 20 s from 7g of a coffee
mixture pressed in packet. Each packet of CC or DC
contained a mixture of 65% Robusta (variety Canephora)
and Arabica (A Morettino s.p.a., Palermo, Italy). The average
caffeine content in 25ml of CC and DC measured by
chromatography–spectrophotometry (Chemical Laboratory,
Camera di Commercio Industria Artigianato e Agricoltura,
Trieste, Italy) was 130mg and 5mg, respectively. No addition
of sugar or milk was permitted.
Measurements
Body composition and fat distribution. Fat mass (percentage
body weight) was estimated as previously described (Verga
et al., 1994) by means of bioelectrical impedance analysis
(BIA-103, RJL, Detroit, MI, USA; Akern, Florence, Italy). Body
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circumference was obtained at the umbilicus (waist circum-
ference) and at the most prominent buttock level (hip
circumference).
Assessment of endothelial function. Endothelium-dependent
reactivity in the macrocirculation, measured by FMD of the
brachial artery, was determined using high-resolution vascular
ultrasound (Sonoline G50; Siemens, Erlangen, Germany)
with a 10MHz linear array transducer. The transducer was
held at the same position throughout the test by a
stereotactic clamp with micrometer adjustment (EDI Progetti
e Sviluppo, Pisa, Italy) to ensure image consistency. Reactive
hyperemia was produced by inflating a sphygmomanometer
cuff 2 cm below the antecubital fossa to occlude the artery
for 5min atB220–250mmHg and then deflating it. A video
processing system computed the brachial artery diameter in
real time by analyzing B-mode ultrasound images (FMD
Studio, Institute of Physiology CNR, Pisa, Italy). Briefly, the
device captures the analog video signal from the ultrasound
equipment. An edge detection algorithm, based on the
localization of gray level discontinuities, automatically
locates the two walls of the vessel. The diameter is obtained
with subpixel precision and temporal resolution of 25
sample(s). The brachial artery diameters were displayed on
a graphical interface over a time scale of 9min. Baseline
vessel size was considered the mean of the measures
obtained during the first minute. The FMD was calculated
as the maximum percentage of increase of the brachial artery
diameter over baseline. These procedures are described in
detail elsewhere (Corretti et al., 2002; Barac et al., 2007;
Deanfield et al., 2007; Buscemi et al., 2009a, b). The intra-
observer coefficient of variation for FMD was 2.9% in our
laboratory.
Laboratory analysis. Basal lipid measurements and uric acid
were ascertained using common clinical chemistry methods
(IL test cholesterol; IL test high-density lipoprotein choles-
terol; IL test triglycerides; IL test uric acid; Instrumentation
Laboratory, Milano, Italy). Low-density lipoprotein choles-
terol concentration was calculated according to the
Friedewald formula (Friedewald, 1972). Plasma glucose
concentrations were measured using the glucose oxidase
method (Instrumentation Laboratory). Blood concentrations
of insulin were measured by radioimmunoassay (Insik-5,
DiaSorin, Saluggia, Italy). Blood concentrations of C-peptide
were measured by electrochemiluminescence (ECLIA; Roche
Diagnostics, Monza, Italy). The homeostasis model assess-
ment of insulin resistance was calculated according to
Matthews et al. (1985).
Statistical analysis
All data are presented as means±standard error of the
means. Basal pairwise comparisons between the two treat-
ments (CC vs DC) were tested for statistical significance
using the paired Student’s t-test. An overall 32 ANOVA
(analysis of variance) for repeated measures was performed to
evaluate the composite effect of the two different (CC and
DC) ingested coffees over time (three periods: baseline, and
30 and 60min) on the parameters of interest. ANOVA for
repeated measures was also carried out separately to detect
significant changes in variables over time within the two
sessions; Bonferroni’s t-test was performed for individual
differences between two time points (paired) when appro-
priate. A two-tailed Po0.05 was considered significant.
All analyses were performed using Systat (Windows version
11.0; San Jose, CA, USA).
Results
The physical and clinical characteristics of subjects included
in the study are reported in Table 1. The effects of CC and DC
on FMD are reported in Table 2 and Figure 1. Despite no
time treatment effect being observed, both systolic and
diastolic blood pressures were higher in the hour following
ingestion in the CC group. In particular, the average increase
in systolic blood pressure from baseline was 2.7% at both
30min (Po0.05) and 60min (Po0.05) after CC ingestion;
similarly, diastolic blood pressure increased from baseline at
an average of 5.9% at both 30min (Po0.05) and 60min
(Po0.05) after CC. The FMD significantly decreased from
baseline until reaching an average maximum of 22.1% at
60min (Po0.05) after CC ingestion. Both systolic and
diastolic blood pressure and FMD did not significantly
Table 1 Characteristics of study participants
Mean±s.e.m. Range
Sex (male/female) 10/10
Age (years) 31±2 25–49
Body weight (kg) 68.7±3.0 51.3–92.6
BMI (kg/m2) 23.9±0.7 20.1–28.0
Waist circumference (cm) 83.1±2.6 66–98
Hip circumference (cm) 91.6±1.4 80–102
Blood glucose (mg per 100ml)
Basal 88±2 74–107
2h After glucose oral load 82±4 59–119
Blood insulin (mU/ml)
Basal 14.9±1.4 8.0–20.0
2 h After glucose oral load 50.0±8.4 22.0–86.0
Total cholesterol (mg per 100ml) 179±7 121–237
HDL-cholesterol (mg per 100ml) 64±6 22–103
Triglycerides (mg per 100ml) 72±5 38–132
Uric acid (mg per 100ml) 4.8±0.3 2.9–8.1
Blood pressure (mmHg)
Systolic 114±3 90–130
Diastolic 73±2 55–90
Heart rate (beats/min) 73±3 55–92
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein.
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change after DC. Table 3 also reports the changes in
metabolic variables following coffee ingestion. There were
no differences in glucose concentration in either group, but
reductions in insulin and C-peptide concentration and in
the homeostasis model assessment of insulin resistance were
observed in the CC group. DC patients had no change in any
of their variables. No significant correlation was observed
between changes in FMD and changes in parameters,
including insulin and C-peptide concentrations, and systolic
and diastolic blood pressure.
Discussion
This study shows that in non-obese healthy subjects,
CC acutely induces significant endothelial dysfunction.
Conversely, DC ingestion seems to improve the endothelial
function, although the change in FMD approached but did
not reach statistical significance. To our knowledge, this is
the first study that has assessed the effects of espresso coffee
on FMD in healthy subjects with a double-blind, crossover
study design in an Italian cohort.
Our results parallel a study of 17 healthy subjects testing
an instant CC or DC with randomized single-blind (operator)
crossover design (Papamichael et al., 2005). Results showed a
significant reduction in FMD after CC ingestion with a
maximum at 60min, but a nonsignificant reduction of FMD
with DC ingestion, contrary to the trend that we observed.
Although FMD was measured for 2h, this may lead to
Table 2 Changes in vital signs and in brachial artery flow-mediated
dilation after ingestion of caffeinated or decaffeinated espresso coffeea
Coffee P-valueb
Caffeinated
(N¼20)
Decaffeinated
(N¼20)
Time Time
treatment
Systolic blood pressure (mmHg)
Basal 113±2 112±2
30min 116±2* 111±2 0.75 0.22
60min 116±2* 111±2
P-valuec 0.003 0.22
Diastolic blood pressure (mmHg)
Basal 68±2 66±2
30min 72±2* 68±2 0.30 0.27
60min 72±2* 67±2
P-valuec 0.001 0.07
Heart rate (beats/min)
Basal 68±2 69±2
30min 69±2 69±1 o0.01 0.63
60min 67±2 68±2
P-valuec 0.27 0.08
Flow-mediated dilation (%)
Basal 7.7±0.6 6.9±0.6
30min 6.3±0.7 8.1±0.9 0.98 o0.005
60min 6.0±0.8* 8.5±0.9
P-valuec 0.04 0.12
Abbreviation: ANOVA, analysis of variance.
aAll values are mean±s.e.m.
b32 ANOVA for repeated measures.
cP-value compares within group values between basal, 30min and 60min for
each variable within each group.
Paired t-test: *Po 0.05 vs both decaffeinated coffee and basal value.
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Figure 1 Brachial artery flow-mediated dilation (FMD) before
(0min) and after (30min, 60min) ingestion of one cup of
caffeinated (dotted line) or decaffeinated (solid line) espresso coffee.
Data are expressed as mean±s.e.m. and are represented by
vertical bars (n¼20). All data were analyzed by using a one-way
ANOVA (analysis of variance) for repeated measures. The effect was
significant (Po0.05) for caffeinated coffee, with a significant
difference observed at 60min compared with 0min (Po0.05;
Bonferroni’s t-test). *Po0.05 indicates significant difference between
caffeinated coffee and decaffeinated coffee.
Table 3 Changes in metabolic variables after ingestion of espresso
coffeea
Coffee P-valueb
Caffeinated Decaffeinated
Glucose (mg per 100ml)
Basal 85.5±2.2 83.1±1.3 0.30
60min 82.2±1.8 83.2±1.4 0.56
P-valuec 0.12 0.94
Insulin (mU/ml)
Basal 15.8±0.9 14.4±0.7 0.08
60min 15.0±0.8 15.2±1.1 0.82
P-valuec 0.047 0.41
C-peptide (ng/ml)
Basal 1.25±0.09 1.21±0.09 0.07
60min 1.18±0.09 1.13±0.09 0.27
P-valuec 0.007 0.12
HOMA-IR
Basal 3.37±0.23 2.95±0.16 0.47
60min 3.06±0.19 3.14±0.25 0.80
P-valuec 0.019 0.36
Abbreviation: HOMA-IR, Homeostasis model assessment of insulin resistance.
aAll values are mean±s.e.m.
bPaired t-test: caffeinated vs decaffeinated.
cPaired t-test: basal vs 60min.
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excessive patient discomfort and potential harm due to
persistent sphygmomanometer compression. Furthermore,
the coffee preparation was not thoroughly standardized,
thereby introducing bias into their results. By measuring
caffeine content in a systematic manner, as we did in our
own study, we feel justified in the accuracy and precision of
our results.
We cannot exclude the possibility that the 22% reduction
in FMDmay be extended on the basis of the slope of the time
course (Figure 1). Subjects were examined for a limited 1h
period to exclude confounders that may influence FMD,
such as prolonged fasting, stress or artificial ischemic
episodes imposed by frequent FMD measurements (Moens
et al., 2005). As the reduction in FMD was not observed after
DC ingestion, we can reasonably attribute the effects of CC
on endothelial function to the presence of caffeine. In
contrast with this hypothesis, two studies on tea consump-
tion (Duffy et al., 2001; Alexopoulos et al., 2008) included a
caffeine control group and showed that acutely administered
caffeine had no effect on FMD. However, these studies differ
slightly with our own study. In particular, Duffy et al.
measured the FMD 2h after caffeine ingestion, whereas we
showed significant changes 1h after coffee ingestion. The
above study included participants with coronary artery
disease, a group of patients expected to have lower FMD
(Kitta et al., 2009), which may not have further been
suppressed by caffeine. Finally, despite being withheld for
12–24h beforehand, the interference of concurrent vaso-
active medications cannot be excluded. In the study by
Alexopoulos et al., FMD was measured at 30, 90 and 120min,
and not at 60min after caffeine ingestion. However, 50% of
studied subjects were smokers, and it was not specified
whether they were habitual coffee consumers, a condition
that, if present, may induce caffeine tolerance (Riksen et al.,
2009). Other confounding factors may have influenced the
Alexopoulos study results, as the presented basal average
value of FMD before caffeine ingestion (4.35%) is generally
considered low for healthy non-obese subjects (Kitta et al.,
2009).
Antioxidants contained in coffee may also be responsible
for the beneficial effects of DC ingestion on FMD. In fact, our
group showed a dose-dependent favorable effect of DC on
FMD (Buscemi et al., 2009a). Caffeic acid and chlorogenic
acid are present in coffee, both of which have antioxidant
properties (Daglia et al., 2000), which thereby may mitigate
the detrimental effects of caffeine contained in CC on FMD.
We cannot therefore exclude the fact that the same amount
of caffeine might produce additional negative effects on
endothelial function when ingested with other commercial
beverage preparations different from coffee that do not
contain antioxidants (Frary et al., 2005). Both animal (Suzuki
et al., 2006) and human (Esposito et al., 2003) studies have
shown that antioxidants improve endothelial function. In
fact, antioxidants are also present in chocolate, which can be
rich in flavanols (polyphenols) known to increase FMD and
affect endothelial dysfunction (Grassi et al., 2008). However,
in this study, no measurement was performed of serum
concentrations of oxidative stress markers that would have
drawn more specific conclusions concerning the role of
oxidative stress in coffee-induced changes in endothelial
function.
Our results support earlier evidence of the association
between increased blood pressure and coffee (Whitsett et al.,
1984; Casiglia et al., 1991) or caffeine intake (Casiglia et al.,
1991; Nurminen et al., 1999), suggesting that CC may have
acute unfavorable cardiovascular effects in healthy subjects.
However, in a study by Corti et al. (2002), espresso DC
increased systolic, but not diastolic, blood pressure in four
subjects, 30 and 60min after coffee ingestion, suggesting
that components of coffee other than caffeine may be
responsible for the pressor effect. The results of our study,
and similarly those of the report on DC (Buscemi et al.,
2009a), do not support the conclusions by Corti et al., which
may be because of the small number of subjects studied or
other methodological bias. For instance, they investigated
the acute pressor effects of DC after ingestion of three cups of
coffee. As these authors do not report the concentrations of
caffeine in each cup of DC, we cannot exclude that a
significant amount of this substance was consumed initially
by the subjects studied. We cannot exclude the fact that
ingestion of three nonsweetened cups of DC may activate, in
nonhabitual coffee drinkers, the sympathetic nervous system
independently from their content.
An interesting potential hypothesis is that the effects that
we observed on FMD and blood pressure may be even more
relevant in subjects who are genetically ‘slow caffeine
metabolizers,’ as recently defined by Cornelis et al. (2006).
In their cohort, the carrier frequency of this gene was 54%,
and it may therefore act as a confounder that can explain the
inconclusive results of epidemiological studies examining
coffee consumption and cardiovascular risk (Klatsky et al.,
2008). Further studies are needed to assess this hypothesis.
Our results suggest that coffee might influence glucose
homeostasis. Although speculative, plasma glucose may
remain unchanged in fasting conditions, despite decreases
in insulin production, if peripheral insulin sensitivity
increases and/or hepatic glucose output decreases.
A previous study showed in 10 patients that CC impairs
postprandial glucose and insulin sensitivity compared with
DC (Moisey et al., 2008). On the contrary, CC impairs insulin
secretion in the fasting state. These data imply that CC
unfavorably affects glucose homeostasis, particularly in
diabetic patients (Lane et al., 2008), subjecting patients with
comorbidities to higher cardiovascular risk.
Despite the nature of our study design, we acknowledge
the limitations of this pilot study. The decaffeinated group
serves as a placebo group in this study, but it cannot entirely
substitute for a caffeine group; therefore, our results can only
be generalized to caffeine-containing coffee consumers. This
volunteer cohort of hospital employees may be healthier
than others. It is unclear whether the washout period of
5–7 days would be adequate in accurately measuring FMD.
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However, owing to the crossover design, we would expect
the differences to be similar in both groups. We acknowledge
that we were grossly underpowered, but our results are
meant to provide directions for future studies in examining
the effect of caffeinated products on endothelial function.
Whether or not acute effects indeed have an impact on
cardiovascular events in the short- or long-term is unknown;
however, our results can provide some preliminary data on
the understanding of such events. This was a homogeneous
population without known risk factors. In reality, patients
with chronic diseases would be on medications, some of
which have antiinflammatory effects (Buus et al., 2007;
Ma¨ki-Peta¨ja¨ et al., 2007). Further studies need to be
performed on such subjects to observe any possible coffee–
disease interaction on endothelial function. Finally, the
study results are limited to the effects of espresso coffee and
not of other preparations, thereby limiting its external
validity to other coffee or populations.
We believe that coffee may show unfavorable acute
cardiovascular and metabolic effects with regard to endo-
thelial function. The ‘coffee paradox,’ though, remains
unresolved. Further studies need to investigate whether
antioxidants contained in coffee can overcome caffeine’s
harmful effects to further our understanding of the conflict-
ing results of the protective effects of coffee consumption on
diabetes and cardiovascular disease.
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